134 related articles for article (PubMed ID: 38237687)
1. Efficient ultrasound-mediated drug delivery to orthotopic liver tumors - Direct comparison of doxorubicin-loaded nanobubbles and microbubbles.
Nittayacharn P; Abenojar E; Cooley MB; Berg FM; Counil C; Sojahrood AJ; Khan MS; Yang C; Berndl E; Golczak M; Kolios MC; Exner AA
J Control Release; 2024 Mar; 367():135-147. PubMed ID: 38237687
[TBL] [Abstract][Full Text] [Related]
2. Efficient ultrasound-mediated drug delivery to orthotopic liver tumors - Direct comparison of doxorubicin-loaded nanobubbles and microbubbles.
Nittayacharn P; Abenojar E; Cooley M; Berg F; Counil C; Sojahrood AJ; Khan MS; Yang C; Berndl E; Golczak M; Kolios MC; Exner AA
bioRxiv; 2023 Sep; ():. PubMed ID: 37732235
[TBL] [Abstract][Full Text] [Related]
3. Increasing Doxorubicin Loading in Lipid-Shelled Perfluoropropane Nanobubbles
Nittayacharn P; Abenojar E; De Leon A; Wegierak D; Exner AA
Front Pharmacol; 2020; 11():644. PubMed ID: 32477125
[TBL] [Abstract][Full Text] [Related]
4. Ultrasound-mediated drug-free theranostics for treatment of prostate cancer.
Perera RH; Berg FM; Abenojar EC; Nittayacharn P; Kim Y; Wang X; Basilion JP; Exner AA
bioRxiv; 2023 Sep; ():. PubMed ID: 37745586
[TBL] [Abstract][Full Text] [Related]
5. Ultrasound-mediated drug-free theranostics for treatment of prostate cancer.
Perera RH; Berg FM; Abenojar EC; Nittayacharn P; Kim Y; Wang X; Basilion JP; Exner A
Bioact Mater; 2024 May; 35():45-55. PubMed ID: 38304914
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor receptor-targeted sonoporation with microbubbles enhances therapeutic efficacy in a squamous cell carcinoma model.
Hirabayashi F; Iwanaga K; Okinaga T; Takahashi O; Ariyoshi W; Suzuki R; Sugii M; Maruyama K; Tominaga K; Nishihara T
PLoS One; 2017; 12(9):e0185293. PubMed ID: 28938010
[TBL] [Abstract][Full Text] [Related]
7. Development of an Antibody Delivery Method for Cancer Treatment by Combining Ultrasound with Therapeutic Antibody-Modified Nanobubbles Using Fc-Binding Polypeptide.
Yano Y; Hamano N; Haruta K; Kobayashi T; Sato M; Kikkawa Y; Endo-Takahashi Y; Tada R; Suzuki R; Maruyama K; Nomizu M; Negishi Y
Pharmaceutics; 2022 Dec; 15(1):. PubMed ID: 36678759
[TBL] [Abstract][Full Text] [Related]
8. Perfusion-guided sonopermeation of neuroblastoma: a novel strategy for monitoring and predicting liposomal doxorubicin uptake
Bellary A; Villarreal A; Eslami R; Undseth QJ; Lec B; Defnet AM; Bagrodia N; Kandel JJ; Borden MA; Shaikh S; Chopra R; Laetsch TW; Delaney LJ; Shaw CM; Eisenbrey JR; Hernandez SL; Sirsi SR
Theranostics; 2020; 10(18):8143-8161. PubMed ID: 32724463
[TBL] [Abstract][Full Text] [Related]
9. Effects of encapsulated gas on stability of lipid-based microbubbles and ultrasound-triggered drug delivery.
Omata D; Maruyama T; Unga J; Hagiwara F; Munakata L; Kageyama S; Shima T; Suzuki Y; Maruyama K; Suzuki R
J Control Release; 2019 Oct; 311-312():65-73. PubMed ID: 31461665
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the synergistic effect of lipid nanobubbles and SonoVue microbubbles for high intensity focused ultrasound thermal ablation of tumors.
Yao Y; Yang K; Cao Y; Zhou X; Xu J; Liu J; Wang Q; Wang Z; Wang D
PeerJ; 2016; 4():e1716. PubMed ID: 26925336
[TBL] [Abstract][Full Text] [Related]
11. Cell-penetrating peptide-doxorubicin conjugate loaded NGR-modified nanobubbles for ultrasound triggered drug delivery.
Lin W; Xie X; Deng J; Liu H; Chen Y; Fu X; Liu H; Yang Y
J Drug Target; 2016; 24(2):134-46. PubMed ID: 26176270
[TBL] [Abstract][Full Text] [Related]
12. Combined legumain- and integrin-targeted nanobubbles for molecular ultrasound imaging of breast cancer.
Mi X; Guo X; Du H; Han M; Liu H; Luo Y; Wang D; Xiang R; Yue S; Zhang Y; Tan X
Nanomedicine; 2022 Jun; 42():102533. PubMed ID: 35150904
[TBL] [Abstract][Full Text] [Related]
13. Development and optimization of doxorubicin loaded poly(lactic-co-glycolic acid) nanobubbles for drug delivery into HeLa cells.
Deng L; Li L; Yang H; Li L; Zhao F; Wu C; Liu Y
J Nanosci Nanotechnol; 2014 Apr; 14(4):2947-54. PubMed ID: 24734715
[TBL] [Abstract][Full Text] [Related]
14. The relationship between surface drug distribution of Dox-loaded microbubbles and drug release/cavitation behaviors with ultrasound.
Lin CW; Fan CH; Yeh CK
Ultrason Sonochem; 2024 Jan; 102():106728. PubMed ID: 38103369
[TBL] [Abstract][Full Text] [Related]
15. The Influence of Nanobubble Size and Stability on Ultrasound Enhanced Drug Delivery.
Batchelor DVB; Armistead FJ; Ingram N; Peyman SA; McLaughlan JR; Coletta PL; Evans SD
Langmuir; 2022 Nov; 38(45):13943-13954. PubMed ID: 36322191
[TBL] [Abstract][Full Text] [Related]
16. Estimating the delivery efficiency of drug-loaded microbubbles in cancer cells with ultrasound and bioluminescence imaging.
Liao AH; Li YK; Lee WJ; Wu MF; Liu HL; Kuo ML
Ultrasound Med Biol; 2012 Nov; 38(11):1938-48. PubMed ID: 22929655
[TBL] [Abstract][Full Text] [Related]
17. Nanobubble-mediated cancer cell sonoporation using low-frequency ultrasound.
Bismuth M; Eck M; Ilovitsh T
Nanoscale; 2023 Nov; 15(44):17899-17909. PubMed ID: 37899700
[TBL] [Abstract][Full Text] [Related]
18. New doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: in-vivo characterization.
Tinkov S; Coester C; Serba S; Geis NA; Katus HA; Winter G; Bekeredjian R
J Control Release; 2010 Dec; 148(3):368-72. PubMed ID: 20868711
[TBL] [Abstract][Full Text] [Related]
19. Ultrasound Mediated Microbubbles Destruction Augmented Sonolysis: An In Vitro and In Vivo Study.
Cui H; Zhu Q; Gao Y; Xia H; Tan K; He Y; Liu Z; Xu Y
Biomed Res Int; 2017; 2017():7021929. PubMed ID: 28900624
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
